Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination

Published:2022-06-24 Issue:6 Volume:5 Page:e2218512
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Weintraub Eric S.¹,Oster Matthew E.¹²,Klein Nicola P.³

Affiliation:

1. Immunization Safety Office, US Centers for Disease Control and Prevention, Atlanta, Georgia

2. Children’s Healthcare of Atlanta, Emory University, Atlanta, Georgia

3. Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2793555/weintraub_2022_ic_220111_1655221508.87623.pdf

Reference7 articles.

1. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021.;Oster;JAMA,2022

2. Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel.;Mevorach;N Engl J Med,2021

3. Surveillance for adverse events after COVID-19 mRNA vaccination.;Klein;JAMA,2021

4. The Advisory Committee on Immunization Practices’ recommendation for use of Moderna COVID-19 vaccine in adults aged =18 years and considerations for extended intervals for administration of primary series doses of mRNA COVID-19 vaccines—United States, February 2022.;Wallace;MMWR Morb Mortal Wkly Rep,2022

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety;Bioactive Materials;2024-08

2. Preliminary Report of Nationwide COVID-19 Vaccine Compensation in Taiwan;Healthcare;2024-06-24

3. Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines;Drugs;2024-04

4. Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis;Life;2024-02-26

5. COVID-19 Autopsy Principles and Protocols;Reference Module in Social Sciences;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3